GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 291.35 Million CNY | -32.7% |
| 2022 | 432.93 Million CNY | 32.05% |
| 2021 | 327.86 Million CNY | -2.36% |
| 2020 | 335.8 Million CNY | 93.63% |
| 2019 | 173.42 Million CNY | -9.47% |
| 2018 | 191.56 Million CNY | 74.15% |
| 2017 | 110 Million CNY | 166.13% |
| 2016 | 41.33 Million CNY | 81.1% |
| 2015 | 22.82 Million CNY | -41.21% |
| 2014 | 38.82 Million CNY | 191.4% |
| 2013 | 13.32 Million CNY | -52.95% |
| 2012 | 28.31 Million CNY | -95.49% |
| 2011 | 627.96 Million CNY | -12.36% |
| 2010 | 716.55 Million CNY | -14.11% |
| 2009 | 834.28 Million CNY | -5.3% |
| 2008 | 880.95 Million CNY | -16.12% |
| 2007 | 1.05 Billion CNY | -0.34% |
| 2006 | 1.05 Billion CNY | -9.93% |
| 2005 | 1.17 Billion CNY | -2.92% |
| 2004 | 1.2 Billion CNY | 8.14% |
| 2003 | 1.11 Billion CNY | 108.84% |
| 2002 | 533.65 Million CNY | 21.66% |
| 2001 | 438.63 Million CNY | 118.32% |
| 2000 | 200.9 Million CNY | 187.79% |
| 1999 | 69.81 Million CNY | -1.13% |
| 1998 | 70.61 Million CNY | 38.97% |
| 1997 | 50.81 Million CNY | 36.37% |
| 1996 | 37.26 Million CNY | 4.78% |
| 1995 | 35.56 Million CNY | 25.87% |
| 1994 | 28.25 Million CNY | 37.47% |
| 1993 | 20.55 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 4.71 Million CNY | -50.91% |
| 2024 Q2 | 79.26 Million CNY | -72.64% |
| 2024 Q1 | 289.77 Million CNY | -0.54% |
| 2023 FY | 291.35 Million CNY | -32.7% |
| 2023 Q3 | 287.72 Million CNY | -9.89% |
| 2023 Q1 | 456.14 Million CNY | 5.36% |
| 2023 Q4 | 291.35 Million CNY | 1.26% |
| 2023 Q2 | 319.31 Million CNY | -30.0% |
| 2022 Q3 | 431.9 Million CNY | 0.0% |
| 2022 FY | 432.93 Million CNY | 32.05% |
| 2022 Q1 | 327.86 Million CNY | 0.0% |
| 2022 Q2 | 431.9 Million CNY | 31.73% |
| 2022 Q4 | 432.93 Million CNY | 0.24% |
| 2021 Q3 | 333.86 Million CNY | 0.0% |
| 2021 Q1 | 280.8 Million CNY | -16.38% |
| 2021 FY | 327.86 Million CNY | -2.36% |
| 2021 Q4 | 327.86 Million CNY | -1.8% |
| 2021 Q2 | 333.86 Million CNY | 18.9% |
| 2020 Q2 | 253.3 Million CNY | 36.92% |
| 2020 Q3 | 339.3 Million CNY | 33.95% |
| 2020 Q4 | 335.8 Million CNY | -1.03% |
| 2020 Q1 | 185 Million CNY | 6.67% |
| 2020 FY | 335.8 Million CNY | 93.63% |
| 2019 Q1 | 193.32 Million CNY | 0.92% |
| 2019 Q2 | 223.32 Million CNY | 15.52% |
| 2019 Q4 | 173.42 Million CNY | -25.67% |
| 2019 FY | 173.42 Million CNY | -9.47% |
| 2019 Q3 | 233.32 Million CNY | 4.48% |
| 2018 Q4 | 191.56 Million CNY | 0.97% |
| 2018 FY | 191.56 Million CNY | 74.15% |
| 2018 Q3 | 189.72 Million CNY | 11.78% |
| 2018 Q1 | 119.72 Million CNY | 8.84% |
| 2018 Q2 | 169.72 Million CNY | 41.76% |
| 2017 Q4 | 110 Million CNY | 251.07% |
| 2017 FY | 110 Million CNY | 166.13% |
| 2017 Q3 | 31.33 Million CNY | 0.0% |
| 2017 Q2 | 31.33 Million CNY | 2250.61% |
| 2017 Q1 | 1.33 Million CNY | -96.78% |
| 2016 Q1 | 1.33 Million CNY | -94.16% |
| 2016 Q4 | 41.33 Million CNY | 93.75% |
| 2016 FY | 41.33 Million CNY | 81.1% |
| 2016 Q2 | 21.33 Million CNY | 1500.41% |
| 2016 Q3 | 21.33 Million CNY | 0.0% |
| 2015 FY | 22.82 Million CNY | -41.21% |
| 2015 Q2 | 49.82 Million CNY | 35.3% |
| 2015 Q4 | 22.82 Million CNY | -54.19% |
| 2015 Q3 | 49.82 Million CNY | 0.0% |
| 2015 Q1 | 36.82 Million CNY | -5.15% |
| 2014 FY | 38.82 Million CNY | 191.4% |
| 2014 Q1 | 13.32 Million CNY | 0.0% |
| 2014 Q4 | 38.82 Million CNY | 191.4% |
| 2014 Q2 | 13.32 Million CNY | 0.0% |
| 2014 Q3 | 13.32 Million CNY | 0.0% |
| 2013 Q3 | 15.16 Million CNY | -32.5% |
| 2013 Q4 | 13.32 Million CNY | -12.13% |
| 2013 Q1 | 28.13 Million CNY | -0.63% |
| 2013 FY | 13.32 Million CNY | -52.95% |
| 2013 Q2 | 22.46 Million CNY | -20.17% |
| 2012 FY | 28.31 Million CNY | -95.49% |
| 2012 Q4 | 28.31 Million CNY | -95.48% |
| 2012 Q3 | 626.96 Million CNY | -0.13% |
| 2012 Q2 | 627.8 Million CNY | 0.16% |
| 2012 Q1 | 626.83 Million CNY | -0.18% |
| 2011 Q1 | 712.32 Million CNY | -0.59% |
| 2011 Q2 | 635.2 Million CNY | -10.83% |
| 2011 Q3 | 634.35 Million CNY | -0.13% |
| 2011 Q4 | 627.96 Million CNY | -1.01% |
| 2011 FY | 627.96 Million CNY | -12.36% |
| 2010 Q2 | 777.62 Million CNY | -6.39% |
| 2010 FY | 716.55 Million CNY | -14.11% |
| 2010 Q1 | 830.72 Million CNY | -0.43% |
| 2010 Q4 | 716.55 Million CNY | -7.9% |
| 2010 Q3 | 778.02 Million CNY | 0.05% |
| 2009 Q1 | 877.8 Million CNY | -0.36% |
| 2009 Q3 | 877.28 Million CNY | 0.14% |
| 2009 Q4 | 834.28 Million CNY | -4.9% |
| 2009 Q2 | 876.03 Million CNY | -0.2% |
| 2009 FY | 834.28 Million CNY | -5.3% |
| 2008 Q1 | 1.04 Billion CNY | -0.45% |
| 2008 Q3 | 803.79 Million CNY | -23.56% |
| 2008 Q4 | 880.95 Million CNY | 9.6% |
| 2008 FY | 880.95 Million CNY | -16.12% |
| 2008 Q2 | 1.05 Billion CNY | 0.58% |
| 2007 Q2 | 1.1 Billion CNY | -0.81% |
| 2007 Q4 | 1.05 Billion CNY | 6.45% |
| 2007 FY | 1.05 Billion CNY | -0.34% |
| 2007 Q1 | 1.1 Billion CNY | 5.3% |
| 2007 Q3 | 986.62 Million CNY | -10.36% |
| 2006 FY | 1.05 Billion CNY | -9.93% |
| 2006 Q1 | 539.76 Million CNY | -53.87% |
| 2006 Q4 | 1.05 Billion CNY | -8.89% |
| 2006 Q3 | 1.15 Billion CNY | 116.42% |
| 2006 Q2 | 534.46 Million CNY | -0.98% |
| 2005 Q3 | 646.99 Million CNY | -20.13% |
| 2005 Q2 | 810.02 Million CNY | 22.91% |
| 2005 Q1 | 659.03 Million CNY | -45.32% |
| 2005 FY | 1.17 Billion CNY | -2.92% |
| 2005 Q4 | 1.17 Billion CNY | 80.84% |
| 2004 FY | 1.2 Billion CNY | 8.14% |
| 2004 Q1 | 647.9 Million CNY | -41.86% |
| 2004 Q3 | 629.75 Million CNY | 0.0% |
| 2004 Q4 | 1.2 Billion CNY | 91.38% |
| 2004 Q2 | 629.75 Million CNY | -2.8% |
| 2003 FY | 1.11 Billion CNY | 108.84% |
| 2003 Q1 | 559.92 Million CNY | 4.92% |
| 2003 Q2 | 618.23 Million CNY | 10.41% |
| 2003 Q3 | 638.48 Million CNY | 3.28% |
| 2003 Q4 | 1.11 Billion CNY | 74.55% |
| 2002 FY | 533.65 Million CNY | 21.66% |
| 2002 Q1 | 422.61 Million CNY | -3.65% |
| 2002 Q2 | 467.27 Million CNY | 10.57% |
| 2002 Q3 | 435.78 Million CNY | -6.74% |
| 2002 Q4 | 533.65 Million CNY | 22.46% |
| 2001 Q2 | 269.71 Million CNY | 0.0% |
| 2001 FY | 438.63 Million CNY | 118.32% |
| 2001 Q4 | 438.63 Million CNY | 0.0% |
| 2000 Q2 | 92.81 Million CNY | 0.0% |
| 2000 Q4 | 200.9 Million CNY | 0.0% |
| 2000 FY | 200.9 Million CNY | 187.79% |
| 1999 FY | 69.81 Million CNY | -1.13% |
| 1999 Q2 | 65.61 Million CNY | 0.0% |
| 1999 Q4 | 69.81 Million CNY | 0.0% |
| 1998 FY | 70.61 Million CNY | 38.97% |
| 1998 Q4 | 70.61 Million CNY | 0.0% |
| 1998 Q2 | 59.31 Million CNY | 0.0% |
| 1997 Q2 | - CNY | 0.0% |
| 1997 FY | 50.81 Million CNY | 36.37% |
| 1997 Q4 | 50.81 Million CNY | 0.0% |
| 1996 Q4 | 37.26 Million CNY | 0.0% |
| 1996 FY | 37.26 Million CNY | 4.78% |
| 1995 FY | 35.56 Million CNY | 25.87% |
| 1994 FY | 28.25 Million CNY | 37.47% |
| 1993 FY | 20.55 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 75.17 Million CNY | -287.568% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 1.33 Billion CNY | 78.139% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.03 Billion CNY | 71.879% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 405.85 Million CNY | 28.21% |
| Aurora Optoelectronics Co.,Ltd. | 29.86 Million CNY | -875.458% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 114.76 Million CNY | -153.872% |
| NanJing Pharmaceutical Company Limited | 11.61 Billion CNY | 97.492% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 150 Million CNY | -94.24% |